David Loew
Vorstandsvorsitzender bei
IPSEN
Vermögen: 16 Mio $ am 31.05.2026
Profil
David G. Loew ist Chief Executive Officer & Director bei Ipsen SA und Chief Executive Officer bei Ipsen Pharma SAS (einer Tochtergesellschaft von Ipsen SA). In der Vergangenheit war er Executive Vice President-Sanofi Pasteur bei Sanofi und Global Head-Product Strategy bei Genentech, Inc.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IPSEN SA 0.1% | 31.12.2025 | 86’940 ( 0.1% ) | 16 Mio $ | 31.05.2026 |
Aktuelle Nachrichten zu David Loew
Aktive Positionen von David Loew
| Unternehmen | Position | Beginn |
|---|---|---|
| IPSEN | Vorstandsvorsitzender | 01.07.2020 |
Ipsen Pharma SAS
 Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorsitzender | 30.07.2020 |
G5 Santé | Direktor/Vorstandsmitglied | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
Ipsen Biopharmaceuticals, Inc.
 Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Vorstandsvorsitzender | 01.07.2020 |
Ehemalige bekannte Positionen von David Loew
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | 15.06.2020 |
GAVI Alliance
 GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Direktor/Vorstandsmitglied | - |
| ROCHE HOLDING AG | Corporate Officer/Principal | - |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Ausbildung von David Loew
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
73
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GAVI Alliance
GAVI Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Ipsen Pharma SAS
Ipsen Pharma SAS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
G5 Santé |
